Literature DB >> 25638421

Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization.

Valerie L Baker1, Morton B Brown2, Barbara Luke3, Kirk P Conrad4.   

Abstract

OBJECTIVE: To determine if number of retrieved oocytes correlates with live birth rate and incidence of low birth weight (LBW).
DESIGN: Retrospective cohort.
SETTING: Not applicable. PATIENT(S): Women undergoing fresh embryo transfer with the use of either autologous (n = 194,627) or donor (n = 37,188) oocytes whose cycles were reported to the Society for Assisted Reproductive Technology in the years 2004-2010. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Live birth rate, birth weight, birth weight z-score, LBW. RESULT(S): For both autologous and donor oocyte cycles, increasing number of retrieved oocytes paralleled live birth rate and embryos available for cryopreservation in most analyses, with all models adjusted for age and previous births. For cycles achieving singleton pregnancy with the use of autologous oocytes via transfer of two embryos, a higher number of retrieved oocytes was associated with lower mean birth weight, lower birth weight z-score, and greater incidence of LBW. In contrast, for cycles using donor oocytes, there was no association of number of retrieved oocytes with measures of birth weight. CONCLUSION(S): A higher number of retrieved oocytes was associated with an increased incidence of LBW in autologous singleton pregnancies resulting from transfer of two embryos, but not in donor oocyte cycles. Although the effect of high oocyte number on the incidence of LBW in autologous cycles was of modest magnitude, further study is warranted to determine if a subgroup of women may be particularly vulnerable.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  In vitro fertilization; birth weight; live birth rate; low birth weight; oocyte number; z-score

Mesh:

Year:  2015        PMID: 25638421      PMCID: PMC4415984          DOI: 10.1016/j.fertnstert.2014.12.120

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  46 in total

1.  Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization.

Authors:  Suleena Kansal Kalra; Sarah J Ratcliffe; Christos Coutifaris; Thomas Molinaro; Kurt T Barnhart
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

Review 2.  Effects of relaxin on arterial dilation, remodeling, and mechanical properties.

Authors:  Kirk P Conrad; Sanjeev G Shroff
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

3.  Factors affecting obstetric outcome of singletons born after IVF.

Authors:  Antonina Sazonova; Karin Källen; Ann Thurin-Kjellberg; Ulla-Britt Wennerholm; Christina Bergh
Journal:  Hum Reprod       Date:  2011-07-19       Impact factor: 6.918

4.  Can the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) be used to accurately report clinic total reproductive potential (TRP)?

Authors:  Judy E Stern; Timothy N Hickman; Donna Kinzer; Alan S Penzias; G David Ball; William E Gibbons
Journal:  Fertil Steril       Date:  2012-01-21       Impact factor: 7.329

Review 5.  Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer.

Authors:  Bruce S Shapiro; Said T Daneshmand; Forest C Garner; Martha Aguirre; Cynthia Hudson
Journal:  Fertil Steril       Date:  2014-05-17       Impact factor: 7.329

Review 6.  Maternal vasodilation in pregnancy: the emerging role of relaxin.

Authors:  Kirk P Conrad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-25       Impact factor: 3.619

7.  Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

Authors:  Sesh Kamal Sunkara; Vivian Rittenberg; Nick Raine-Fenning; Siladitya Bhattacharya; Javier Zamora; Arri Coomarasamy
Journal:  Hum Reprod       Date:  2011-05-10       Impact factor: 6.918

8.  Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis.

Authors:  E Labarta; J A Martínez-Conejero; P Alamá; J A Horcajadas; A Pellicer; C Simón; E Bosch
Journal:  Hum Reprod       Date:  2011-05-02       Impact factor: 6.918

9.  Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization.

Authors:  Anthony N Imudia; Awoniyi O Awonuga; Joseph O Doyle; Anjali J Kaimal; Diane L Wright; Thomas L Toth; Aaron K Styer
Journal:  Fertil Steril       Date:  2012-04-10       Impact factor: 7.329

10.  Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles.

Authors:  Ryan G Steward; Lan Lan; Anish A Shah; Jason S Yeh; Thomas M Price; James M Goldfarb; Suheil J Muasher
Journal:  Fertil Steril       Date:  2014-01-23       Impact factor: 7.329

View more
  26 in total

1.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

2.  Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF.

Authors:  Winifred Mak; Laxmi A Kondapalli; Gerard Celia; John Gordon; Michael DiMattina; Mark Payson
Journal:  Hum Reprod       Date:  2016-02-22       Impact factor: 6.918

3.  Role of ICSI in Non-male Factor Cycles as the Number of Oocytes Retrieved Decreases from Four to One.

Authors:  Na Guo; Xiang Hua; Yu-Feng Li; Lei Jin
Journal:  Curr Med Sci       Date:  2018-03-15

4.  Factors predicting double embryo implantation following double embryo transfer in assisted reproductive technology: implications for elective single embryo transfer.

Authors:  Caitlin Martin; Jeani Chang; Sheree Boulet; Denise J Jamieson; Dmitry Kissin
Journal:  J Assist Reprod Genet       Date:  2016-07-14       Impact factor: 3.412

5.  Frozen embryo transfer can be performed in the cycle immediately following the freeze-all cycle.

Authors:  Kemal Ozgur; Hasan Bulut; Murat Berkkanoglu; Peter Humaidan; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2017-09-22       Impact factor: 3.412

6.  Collection of pregnancy outcome records following infertility-challenges and possible solutions.

Authors:  Erin G Floyd; Frauke von Versen-Höynck; Jing Liu; Yueh-Yun Chi; Raquel R Fleischmann; Valerie L Baker
Journal:  J Assist Reprod Genet       Date:  2016-05-26       Impact factor: 3.412

7.  Prediction of live birth and cumulative live birth rates in freeze-all-IVF treatment of a general population.

Authors:  Kemal Ozgur; Hasan Bulut; Murat Berkkanoglu; Levent Donmez; Kevin Coetzee
Journal:  J Assist Reprod Genet       Date:  2019-02-21       Impact factor: 3.412

8.  Total number of oocytes and zygotes are predictive of live birth pregnancy in fresh donor oocyte in vitro fertilization cycles.

Authors:  Eduardo Hariton; Keewan Kim; Sunni L Mumford; Marissa Palmor; Pietro Bortoletto; Eden R Cardozo; Anatte E Karmon; Mary E Sabatini; Aaron K Styer
Journal:  Fertil Steril       Date:  2017-06-07       Impact factor: 7.329

9.  Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.

Authors:  Yuan-hui Chen; Xiao-hang Xu; Qian Wang; Shao-di Zhang; Li-le Jiang; Cui-lian Zhang; Zhao-jia Ge
Journal:  J Assist Reprod Genet       Date:  2015-09-17       Impact factor: 3.412

10.  Effect of oocyte donor stimulation on recipient outcomes: data from a US national donor oocyte bank.

Authors:  H S Hipp; A J Gaskins; Z P Nagy; S M Capelouto; D B Shapiro; J B Spencer
Journal:  Hum Reprod       Date:  2020-04-28       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.